مورد إلكتروني

Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA) : study protocol for a randomized controlled trial

التفاصيل البيبلوغرافية
العنوان: Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA) : study protocol for a randomized controlled trial
بيانات النشر: Linköpings universitet, Avdelningen för kirurgi, ortopedi och onkologi Linköpings universitet, Medicinska fakulteten Region Östergötland, Kirurgiska kliniken US Univ Amsterdam, Netherlands Univ Amsterdam, Netherlands Univ Amsterdam, Netherlands; Inst Osped Fdn Poliambulanza, Italy Univ Amsterdam, Netherlands Univ Amsterdam, Netherlands Morriston Hosp, Wales Virginia Mason Med Ctr, WA 98101 USA Univ Hosp Southampton NHS Fdn Trust, England Univ Pisa, Italy Sahlgrens Univ Hosp, Sweden Univ Amsterdam, Netherlands Pederzoli Hosp, Italy Univ Bologna, Italy Amsterdam UMC, Netherlands Beaujon Hosp, France Oslo Univ Hosp, Norway; Inst Clin Med, Norway Erasmus MC Canc Inst, Netherlands Univ Hosp Verona, Italy Hop St Eloi, France Univ Vita Salute, Italy Osped Niguarda Ca Granda, Italy Inst Mutualiste Montsouris, France Erasmus MC Canc Inst, Netherlands Heidelberg Univ Hosp, Germany Dept Surg, Germany Moscow Clin Sci Ctr, Russia Univ Med Ctr Groningen, Netherlands Univ Helsinki, Finland; Helsinki Univ Hosp, Finland Emory Univ Hosp, GA 30322 USA Med Spectrum Twente, Netherlands Catharina Hosp, Netherlands Univ Hosp Birmingham, England Kings Coll Hosp NHS Fdn Trust, England Univ Med Ctr Utrecht, Netherlands Univ Hosp Verona, Italy IRCCS Policlin San Matteo Pavia, Italy Virginia Mason Med Ctr, WA 98101 USA Inst Osped Fdn Poliambulanza, Italy Hosp del Mar, Spain Ctr Hosp Reg Orleans, France Emory Univ Hosp, GA 30322 USA Oxford Univ Hosp NHS Fdn Trust, England Univ Med Ctr Ljubljana, Slovenia Univ Oslo, Norway Amsterdam UMC, Netherlands Freeman Hosp Newcastle Upon Tyne, England Amsterdam UMC, Netherlands IRCCS, Italy; Humanitas Univ, Italy Univ Amsterdam, Netherlands Univ Amsterdam, Netherlands Inst Osped Fdn Poliambulanza, Italy; Fdn Poliambulanza Inst Osped, Italy BMC 2021
تفاصيل مُضافة: van Hilst, Jony
Korrel, Maarten
Lof, Sanne
de Rooij, Thijs
Vissers, Frederique
Al-Sarireh, Bilal
Alseidi, Adnan
Bateman, Adrian C.
Björnsson, Bergthor
Boggi, Ugo
Bratlie, Svein Olav
Busch, Olivier
Butturini, Giovanni
Casadei, Riccardo
Dijk, Frederike
Dokmak, Safi
Edwin, Bjorn
van Eijck, Casper
Esposito, Alessandro
Fabre, Jean-Michel
Falconi, Massimo
Ferrari, Giovanni
Fuks, David
Koerkamp, Bas Groot
Hackert, Thilo
Keck, Tobias
Khatkov, Igor
de Kleine, Ruben
Kokkola, Arto
Kooby, David A.
Lips, Daan
Luyer, Misha
Marudanayagam, Ravi
Menon, Krishna
Molenaar, Quintus
de Pastena, Matteo
Pietrabissa, Andrea
Rajak, Rushda
Rosso, Edoardo
Sanchez Velazquez, Patricia
Saint Marc, Olivier
Shah, Mihir
Soonawalla, Zahir
Tomazic, Ales
Verbeke, Caroline
Verheij, Joanne
White, Steven
Wilmink, Hanneke W.
Zerbi, Alessandro
Dijkgraaf, Marcel G.
Besselink, Marc G.
Abu Hilal, Mohammad
نوع الوثيقة: Electronic Resource
مستخلص: Background: Recently, the first randomized trials comparing minimally invasive distal pancreatectomy (MIDP) with open distal pancreatectomy (ODP) for non-malignant and malignant disease showed a 2-day reduction in time to functional recovery after MIDP. However, for pancreatic ductal adenocarcinoma (PDAC), concerns have been raised regarding the oncologic safety (i.e., radical resection, lymph node retrieval, and survival) of MIDP, as compared to ODP. Therefore, a randomized controlled trial comparing MIDP and ODP in PDAC regarding oncological safety is warranted. We hypothesize that the microscopically radical resection (R0) rate is non-inferior for MIDP, as compared to ODP. Methods/design: DIPLOMA is an international randomized controlled, patient- and pathologist-blinded, non-inferiority trial performed in 38 pancreatic centers in Europe and the USA. A total of 258 patients with an indication for elective distal pancreatectomy with splenectomy because of proven or highly suspected PDAC of the pancreatic body or tail will be randomly allocated to MIDP (laparoscopic or robot-assisted) or ODP in a 1:1 ratio. The primary outcome is the microscopically radical resection margin (R0, distance tumor to pancreatic transection and posterior margin >= 1 mm), which is assessed using a standardized histopathology assessment protocol. The sample size is calculated with the following assumptions: 5% one-sided significance level (alpha), 80% power (1-beta), expected R0 rate in the open group of 58%, expected R0 resection rate in the minimally invasive group of 67%, and a non-inferiority margin of 7%. Secondary outcomes include time to functional recovery, operative outcomes (e.g., blood loss, operative time, and conversion to open surgery), other histopathology findings (e.g., lymph node retrieval, perineural- and lymphovascular invasion), postoperative outcomes (e.g., clinically relevant complications, hospital stay, and administration of adjuvant treatment), time and si
Funding Agencies|Covidien AG (Medtronic, Neuhausen am Rheinfall, Switzerland) [ISR2017-10928]
مصطلحات الفهرس: Minimally invasive; Laparoscopic; Robot-assisted; Distal pancreatectomy; Left pancreatectomy; Pancreatic tail resection; Pancreatic surgery; Pancreatic cancer; Pancreatic ductal adenocarcinoma, Surgery, Kirurgi, Article in journal, info:eu-repo/semantics/article, text
DOI: 10.1186.s13063-021-05506-z
URL: http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-179606
Trials, 1745-6215, 2021, 22:1
الإتاحة: Open access content. Open access content
info:eu-repo/semantics/openAccess
ملاحظة: application/pdf
English
أرقام أخرى: UPE oai:DiVA.org:liu-179606
doi:10.1186/s13063-021-05506-z
PMID 34503548
ISI:000694894400001
1280620073
المصدر المساهم: UPPSALA UNIV LIBR
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.on1280620073
قاعدة البيانات: OAIster
الوصف
DOI:10.1186.s13063-021-05506-z